High-Purity Methyl 4-Fluoro-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzoate Manufacturer | Pharmaceutical Intermediate for Cancer Therapy

Discover a critical pharmaceutical intermediate, Methyl 4-Fluoro-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzoate (CAS 1235865-75-4), essential for synthesizing Venetoclax, a leading BCL-2 inhibitor. As a trusted manufacturer and supplier in China, we provide high-quality intermediates crucial for advanced cancer therapies. Explore our offerings and secure your supply chain for critical pharmaceutical raw materials.

Get a Quote & Sample

Advantages of Partnering with Us for Your Pharmaceutical Intermediate Needs

Uncompromised Quality and Purity

We ensure that our Methyl 4-Fluoro-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzoate intermediate meets rigorous purity standards required for pharmaceutical applications, vital for the efficacy of Venetoclax synthesis. Partner with us to buy with confidence.

Secure and Stable Supply Chain

Leveraging our robust manufacturing capabilities, we provide a stable and reliable supply of this key intermediate, crucial for uninterrupted drug production. As a dedicated manufacturer, we guarantee availability for your purchase.

Competitive Manufacturer Pricing

Obtain direct manufacturer pricing for Methyl 4-Fluoro-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzoate. We aim to provide cost-effective solutions for pharmaceutical companies worldwide looking to purchase this critical intermediate.

Key Applications and Therapeutic Significance

Venetoclax Synthesis

This intermediate is a cornerstone in the multi-step synthesis of Venetoclax, a targeted therapy that has revolutionized the treatment landscape for certain hematological malignancies. We are a trusted supplier for this critical synthesis step.

Chronic Lymphocytic Leukemia (CLL) Treatment

Its role in Venetoclax production makes it indirectly vital for treating CLL, offering a new hope for patients. Pharmaceutical buyers can inquire about bulk purchase options.

Estrogen Receptor-Positive Breast Cancer Research

Ongoing research explores its application in developing therapies for ER-positive breast cancer, highlighting its broader therapeutic potential. Connect with us for R&D quantities.

Oncology Drug Development

As a foundational component for advanced oncology drugs, it is a key raw material for pharmaceutical companies engaged in novel drug development. Get a quote today to secure your supply.

Related Technical Articles & Resources

No related articles found.